Pfizer Inc. (PFE) Announces Partnership With Shanghai Institutes for Biological Sciences For Drug Discovery Activities
7/29/2009 9:42:12 AM
SHANGHAI, China--(BUSINESS WIRE)--Pfizer today announced a joint initiative with the Shanghai Institutes for Biological Sciences (SIBS) to support fundamental research in China. As part of the initiative, Pfizer China will provide US$500,000 each year over three years to fund health-related fundamental research projects at SIBS and its application to drug discovery and development programs in the country. This is the latest in a series of Pfizer initiatives aimed at supporting China as it becomes one of the leading contributors to healthcare innovation worldwide.